Search Results for: KEAP1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ICAM1 intercellular adhesion molecule 1
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Integrin cell surface interactions
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interferon gamma signaling
  • Natalizumab
  • Hyaluronic acid
  • Nafamostat
  • Allograft rejection
Novel IFIH1 interferon induced with helicase C domain 1
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • Negative regulators of DDX58/IFIH1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Evasion by RSV of host interferon responses
  • Modulation of host responses by IFN-stimulated genes
  • Type I diabetes mellitus
Novel IPO11 importin 11
Novel IQCC IQ motif containing C
Novel IRF1 interferon regulatory factor 1
  • Pyroptosis
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Regulation of PD-L1(CD274) transcription
Novel KLHL12 kelch like family member 12
  • Degradation of DVL
Novel KLHL24 kelch like family member 24
Novel KPNA6 karyopherin subunit alpha 6
  • Assembly of the ORC complex at the origin of replication
Novel LAMC1 laminin subunit gamma 1
  • Degradation of the extracellular matrix
  • Laminin interactions
  • Laminin interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • L1CAM interactions
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • MET activates PTK2 signaling
  • Post-translational protein phosphorylation
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Attachment of bacteria to epithelial cells
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Developmental Lineage of Pancreatic Ductal Cells
  • Lanoteplase
Novel LAMTOR5 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
  • Macroautophagy
  • MTOR signalling
  • mTORC1-mediated signalling
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of PTEN gene transcription
  • Amino acids regulate mTORC1
Novel LINC00239 long intergenic non-protein coding RNA 239
Novel LONP1 lon peptidase 1, mitochondrial
  • Mitochondrial protein degradation
  • Mitochondrial unfolded protein response (UPRmt)
Novel LSM3 LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
  • mRNA decay by 5' to 3' exoribonuclease
  • mRNA decay by 5' to 3' exoribonuclease
  • mRNA Splicing - Major Pathway
Novel MAD2L1 mitotic arrest deficient 2 like 1
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC-Cdc20 mediated degradation of Nek2A
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • RHO GTPases Activate Formins
  • Mitotic Prometaphase
  • EML4 and NUDC in mitotic spindle formation
Novel MAPKBP1 mitogen-activated protein kinase binding protein 1
Novel MCC MCC regulator of Wnt signaling pathway
Novel MCMBP minichromosome maintenance complex binding protein
Novel MLST8 MTOR associated protein MLST8
  • PIP3 activates AKT signaling
  • Macroautophagy
  • MTOR signalling
  • mTORC1-mediated signalling
  • HSF1-dependent transactivation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • CD28 dependent PI3K/Akt signaling
  • VEGFR2 mediated vascular permeability
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • Regulation of PTEN gene transcription
  • Amino acids regulate mTORC1
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Novel MYO7A myosin VIIA
  • The canonical retinoid cycle in rods (twilight vision)
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
  • Deafness, autosomal recessive
  • Usher syndrome (US)
  • Deafness, autosomal dominant
Novel NFE2L2 NFE2 like bZIP transcription factor 2
  • Neddylation
  • Potential therapeutics for SARS
  • Regulation of HMOX1 expression and activity
  • Heme signaling
  • KEAP1-NFE2L2 pathway
  • KEAP1-NFE2L2 pathway
  • Nuclear events mediated by NFE2L2
  • GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
  • NFE2L2 regulating TCA cycle genes
  • NFE2L2 regulating inflammation associated genes
  • NFE2L2 regulating anti-oxidant/detoxification enzymes
  • NFE2L2 regulates pentose phosphate pathway genes
  • NFE2L2 regulating tumorigenic genes
  • NFE2L2 regulating MDR associated enzymes
  • NFE2L2 regulating ER-stress associated genes
  • Regulation of NFE2L2 gene expression
  • Regulation of NFE2L2 gene expression
  • Regulation of PD-L1(CD274) transcription

Page 3 out of 11 pages